These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35041315)

  • 1. [Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules].
    Gromova OA; Torshin IY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):69-76. PubMed ID: 35041315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture.
    Solanki P; Prasad D; Muthuraju S; Sharma AK; Singh SB; Ilavzhagan G
    Food Chem Toxicol; 2011 Apr; 49(4):917-22. PubMed ID: 21193009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hypoxic effect of piracetam and its interaction with prostacyclin.
    Nikolova M; Nikolov R; Milanova D
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):367-71. PubMed ID: 6390021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine.
    Abdel-Salam OM; Khadrawy YA; Salem NA; Sleem AA
    Neurochem Res; 2011 Jun; 36(6):1062-72. PubMed ID: 21448596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinpocetine and piracetam exert antinociceptive effect in visceral pain model in mice.
    Abdel Salam OM
    Pharmacol Rep; 2006; 58(5):680-91. PubMed ID: 17085860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scavenger effect of various cerebrovascular drugs].
    Horváth B; Márton Z; Halmosi R; Alexy T; Szapáry L; Vékási J; Bíró Z; Habon T; Késmárky G; Tóth K
    Orv Hetil; 2002 Jan; 143(1):13-7. PubMed ID: 11816373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration.
    Nasr M; Wahdan SA
    Life Sci; 2019 Jun; 226():117-129. PubMed ID: 30981765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The action of piracetam, meclofenoxate and vinpocetine in comparative disease models in mice].
    Fischer W; Kittner H; Schubert S
    Pharmazie; 1991 May; 46(5):359-60. PubMed ID: 1896483
    [No Abstract]   [Full Text] [Related]  

  • 9. The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells.
    Zelles T; Franklin L; Koncz I; Lendvai B; Zsilla G
    Neurochem Res; 2001 Sep; 26(8-9):1095-100. PubMed ID: 11699936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine.
    Horvath B; Marton Z; Halmosi R; Alexy T; Szapary L; Vekasi J; Biro Z; Habon T; Kesmarky G; Toth K
    Clin Neuropharmacol; 2002; 25(1):37-42. PubMed ID: 11852295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.
    Zaitone SA; Abo-Elmatty DM; Elshazly SM
    Indian J Pharmacol; 2012; 44(6):774-9. PubMed ID: 23248410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons.
    Tárnok K; Kiss E; Luiten PG; Nyakas C; Tihanyi K; Schlett K; Eisel UL
    Neurochem Int; 2008 Dec; 53(6-8):289-95. PubMed ID: 18793690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nootropic drugs reduce immobility in behavioural despair test in mice.
    Schmidt J
    Biomed Biochim Acta; 1984; 43(11):1295-9. PubMed ID: 6442578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons.
    Bukanova JV; Solntseva EI; Skrebitsky VG
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):229-37. PubMed ID: 12366875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nootropic drug vinpocetine modulates different types of potassium currents in molluscan neurons.
    Solntseva EI; Bukanova JV; Skrebitsky VG
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Feb; 128(2):275-80. PubMed ID: 11239840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vinpocetine in cerebrovascular diseases.
    Patyar S; Prakash A; Modi M; Medhi B
    Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation.
    Gabryel B; Adamek M; Pudełko A; Małecki A; Trzeciak HI
    Neurotoxicology; 2002 May; 23(1):19-31. PubMed ID: 12164545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells.
    Pereira C; Agostinho P; Oliveira CR
    Free Radic Res; 2000 Nov; 33(5):497-506. PubMed ID: 11200083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The nootropic agent vinpocetine blocks the delayed rectifier potassium channel more strongly than the high-conductance calcium channel].
    Bukanova IuV; Solntseva EI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(5):911-6. PubMed ID: 9054143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.